NTK Institute Logo Mission Statement - Dedicated to improving medical practice through the immediate delivery of new clinically-relevant science to physicians who most urgently need to know about this science Need-To-Know Science Scoring System
About The Institute
NTK Initiative
NTK Watch
Recently Scored Science
Contact Us
To sign up to receive the NTK Watch daily e-mail
All alendronate News
07/07/2014 The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment (Aging Clin Exp Res)
05/30/2014 Incidence and Risk of Venous Thromboembolism Among Taiwan Osteoporotic Fracture Population under Osteoporosis Pharmacological Treatments (J Clin Endocrinol Metab)
05/13/2014 Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy: The FLEX Study (JAMA Intern Med)
05/06/2014 Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials (J Bone Miner Metab)
04/29/2014 Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis (Osteoporos Int)
04/17/2014 The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate (Bone)
04/11/2014 Fracture Risk Reduction with Denosumab in Japanese Postmenopausal Women and Men with Osteoporosis: Denosumab fracture Intervention RandomizEd placebo Controlled Trial (DIRECT) (J Clin Endocrinol Metab)
04/08/2014 Established and forthcoming drugs for the treatment of osteoporosis (Curr Opin Rheumatol)
04/03/2014 Use of strontium ranelate and risk of acute coronary syndrome: cohort study (Ann Rheum Dis)
04/01/2014 Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis (J Clin Pharm Ther)
03/27/2014 External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review (Osteoporos Int)
03/27/2014 Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy (Rheumatol Int)
03/26/2014 The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab (Gynecol Endocrinol)
03/24/2014 Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis (Menopause)
03/20/2014 Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate (Clin Rheumatol)
03/10/2014 Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss (Osteoporos Int)
03/10/2014 Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study (Osteoporos Int)
03/10/2014 Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis (Osteoporos Int)
03/07/2014 Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population (Osteoporos Int)
02/18/2014 A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment (Bone)
01/10/2014 Differing Effects of Denosumab and Alendronate on Cortical and Trabecular Bone (Bone)
01/10/2014 Effects of Teriparatide on Cortical Histomorphometric Variables in Postmenopausal Women With or Without Prior Alendronate Treatment (Bone)
01/08/2014 A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy (Foot Ankle Surg)
12/20/2013 Update on Long-Term Treatment With Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review (Bone)
12/18/2013 Natural history and risk factors for adjacent vertebral fractures in the fracture intervention trial (Spine)
12/11/2013 The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis (Osteoporos Int)
12/05/2013 Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful? (Aging Clin Exp Res)
12/05/2013 Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing (Osteoporos Int)
12/03/2013 Comparative Effectiveness of Osteoporosis Drugs in Preventing Secondary Non-vertebral Fractures in Taiwanese Women (J Clin Endocrinol Metab)
12/03/2013 COMPARISON OF ALENDRONATE AND RALOXIFENE FOR THE MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM (J Endocrinol Invest)


 1  2  3     Next


Copyright © 2014, NTK Institute |  Terms and Conditions  |  Privacy Policy